FOLD Market Structure

Amicus Therapeutics, Inc. (FOLD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.55B, listed on NASDAQ, employing roughly 499 people, carrying a beta of 0.48 to the broader market. Amicus Therapeutics, Inc. Led by Bradley L. Campbell, public since 2007-05-31.

Market structure data reveals where a stock trades across exchanges, dark pools, and alternative trading systems. Understanding off-exchange activity helps identify institutional trading patterns and liquidity dynamics.

Latest Week Ending

2026-04-20

Weekly OTC Shares

3.4M

Weekly OTC Trades

7.0K

12-Week Total Shares

85.0M

Avg Trade Size (12-Week)

1.1K shares

How Single-Name Off-Exchange Volume Affects Options

For single-name equities, persistent off-exchange volume concentrations can flag institutional positioning - large blocks arranged through ATS venues to avoid lit-market impact, or correlation-arbitrage flow from sector rotation. The flow doesn't directly move the lit-market price (it prints at the ATS) but it changes the inventory position of the institutional counterparty, which then drives subsequent lit-market flow. Compare the off-exchange volume series above with FOLD's gamma exposure and options volume history to see whether unusual dark-pool activity coincides with rebalancing in the options book.

Showing 12 weeks of off-exchange trading data for Amicus Therapeutics, Inc..

Learn how market structure is reported and how to read the data →